This table contains 2394 series, with data for years 1991 - 1991 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (1 items: Canada ...), Population group (19 items: Entire cohort; Income adequacy quintile 1 (lowest);Income adequacy quintile 2;Income adequacy quintile 3 ...), Age (14 items: At 25 years; At 30 years; At 40 years; At 35 years ...), Sex (3 items: Both sexes; Females; Males ...), Characteristics (3 items: Life expectancy; High 95% confidence interval; life expectancy; Low 95% confidence interval; life expectancy ...).

International estimates of mean life expectancy at age 40, by country for men and women

Life expectancy at birth and at age 65, by sex, on a three-year average basis.

In 2024, the average life expectancy in the world was 71 years for men and 76 years for women. The lowest life expectancies were found in Africa, while Oceania and Europe had the highest. What is life expectancy?Life expectancy is defined as a statistical measure of how long a person may live, based on demographic factors such as gender, current age, and most importantly the year of their birth. The most commonly used measure of life expectancy is life expectancy at birth or at age zero. The calculation is based on the assumption that mortality rates at each age were to remain constant in the future. Life expectancy has changed drastically over time, especially during the past 200 years. In the early 20th century, the average life expectancy at birth in the developed world stood at 31 years. It has grown to an average of 70 and 75 years for males and females respectively, and is expected to keep on growing with advances in medical treatment and living standards continuing. Highest and lowest life expectancy worldwide Life expectancy still varies greatly between different regions and countries of the world. The biggest impact on life expectancy is the quality of public health, medical care, and diet. As of 2022, the countries with the highest life expectancy were Japan, Liechtenstein, Switzerland, and Australia, all at 84–83 years. Most of the countries with the lowest life expectancy are mostly African countries. The ranking was led by the Chad, Nigeria, and Lesotho with 53–54 years.

Mean, median and modal ages at death in the UK and its constituent countries, 2001 to 2003 and 2016 to 2018.

Life expectancy is the average number of years of life left at a particular age, based on death rates for a given period. This is a hypothetical measure useful for tracking mortality trends in the population.

The average number of years that a group of individuals could expect to live at a given age if they are at risk of dying observed at each age during the reference year(s). The calculation is done over several years in order to have a more stable estimate. Note: The entity's life expectancy may be influenced by the presence or absence of a nursing home in the entity's territory. Although the calculation includes all the deaths observed over the selected period, the impact of some deaths on life expectancy remains greater in a sparsely populated entity. The classification of entities according to their life expectancy should therefore be interpreted with caution.

Dataset replaced by: http://data.europa.eu/euodp/data/dataset/tHJ7RfJO3ZAXvnwP5Jm5kw The indicator Healthy Life Years (HLY) at age 65 measures the number of years that a person at age 65 is still expected to live in a healthy condition. HLY is a health expectancy indicator which combines information on mortality and morbidity. The data required are the age-specific prevalence (proportions) of the population in healthy and unhealthy conditions and age-specific mortality information. A healthy condition is defined by the absence of limitations in functioning/disability. The indicator is calculated separately for males and females. The indicator is also called disability-free life expectancy (DFLE). Life expectancy at age 65 is defined as the mean number of years still to be lived by a person at age 65, if subjected throughout the rest of his or her life to the current mortality conditions.

San Marino Life Expectancy at Birth: Male data was reported at 84.100 Year in 2012. San Marino Life Expectancy at Birth: Male data is updated yearly, averaging 84.100 Year from Dec 2012 (Median) to 2012, with 1 observations. San Marino Life Expectancy at Birth: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s San Marino – Table SM.World Bank.WDI: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

Abstract

The Health Inequality Project uses big data to measure differences in life expectancy by income across areas and identify strategies to improve health outcomes for low-income Americans.

Section 7

This table reports life expectancy point estimates and standard errors for men and women at age 40 for each percentile of the national income distribution. Both race-adjusted and unadjusted estimates are reported.

Source

Section 13

This table reports life expectancy point estimates and standard errors for men and women at age 40 for each percentile of the national income distribution separately by year. Both race-adjusted and unadjusted estimates are reported.

Source

Section 6

This dataset was created on 2020-01-10 18:53:00.508 by merging multiple datasets together. The source datasets for this version were:

Commuting Zone Life Expectancy Estimates by year: CZ-level by-year life expectancy estimates for men and women, by income quartile

Commuting Zone Life Expectancy: Commuting zone (CZ)-level life expectancy estimates for men and women, by income quartile

Commuting Zone Life Expectancy Trends: CZ-level estimates of trends in life expectancy for men and women, by income quartile

Commuting Zone Characteristics: CZ-level characteristics

Commuting Zone Life Expectancy for larger populations: CZ-level life expectancy estimates for men and women, by income ventile

Section 15

This table reports life expectancy point estimates and standard errors for men and women at age 40 for each quartile of the national income distribution by state of residence and year. Both race-adjusted and unadjusted estimates are reported.

Source

Section 11

This table reports US mortality rates by gender, age, year and household income percentile. Household incomes are measured two years prior to the mortality rate for mortality rates at ages 40-63, and at age 61 for mortality rates at ages 64-76. The “lag” variable indicates the number of years between measurement of income and mortality.

Observations with 1 or 2 deaths have been masked: all mortality rates that reflect only 1 or 2 deaths have been recoded to reflect 3 deaths

Source

Section 3

This table reports coefficients and standard errors from regressions of life expectancy estimates for men and women at age 40 for each quartile of the national income distribution on calendar year by commuting zone of residence. Only the slope coefficient, representing the average increase or decrease in life expectancy per year, is reported. Trend estimates for both race-adjusted and unadjusted life expectancies are reported. Estimates are reported for the 100 largest CZs (populations greater than 590,000) only.

Source

Section 9

This table reports life expectancy estimates at age 40 for Males and Females for all countries. Source: World Health Organization, accessed at: http://apps.who.int/gho/athena/

Source

Section 10

This table reports life expectancy point estimates and standard errors for men and women at age 40 for each quartile of the national income distribution by county of residence. Both race-adjusted and unadjusted estimates are reported. Estimates are reported for counties with populations larger than 25,000 only

Source

Section 2

This table reports life expectancy point estimates and standard errors for men and women at age 40 for each quartile of the national income distribution by commuting zone of residence and year. Both race-adjusted and unadjusted estimates are reported. Estimates are reported for the 100 largest CZs (populations greater than 590,000) only.

Source

Section 8

This table reports US population and death counts by age, year, and sex from various sources. Counts labelled “dm1” are derived from the Social Security Administration Data Master 1 file. Counts labelled “irs” are derived from tax data. Counts labelled “cdc” are derived from NCHS life tables.

Source

Section 12

This table reports numerous county characteristics, compiled from various sources. These characteristics are described in the county life expectancy table.

Two variables constructed by the Cen

This table contains 2754 series, with data for years 2005/2007 - 2012/2014 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (153 items: Canada; Newfoundland and Labrador; Eastern Regional Integrated Health Authority, Newfoundland and Labrador; Central Regional Integrated Health Authority, Newfoundland and Labrador; ...);  Age group (2 items: At birth; At age 65);  Sex (3 items: Both sexes; Males; Females);  Characteristics (3 items: Life expectancy; Low 95% confidence interval, life expectancy; High 95% confidence interval, life expectancy).

Haiti HT: Life Expectancy at Birth: Male data was reported at 61.162 Year in 2016. This records an increase from the previous number of 60.902 Year for 2015. Haiti HT: Life Expectancy at Birth: Male data is updated yearly, averaging 52.441 Year from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 61.162 Year in 2016 and a record low of 40.804 Year in 1960. Haiti HT: Life Expectancy at Birth: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Haiti – Table HT.World Bank: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

Philippines PH: Life Expectancy at Birth: Male data was reported at 65.812 Year in 2016. This records an increase from the previous number of 65.684 Year for 2015. Philippines PH: Life Expectancy at Birth: Male data is updated yearly, averaging 62.175 Year from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 65.812 Year in 2016 and a record low of 56.609 Year in 1960. Philippines PH: Life Expectancy at Birth: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Philippines – Table PH.World Bank: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

Iran IR: Life Expectancy at Birth: Male data was reported at 74.882 Year in 2016. This records an increase from the previous number of 74.668 Year for 2015. Iran IR: Life Expectancy at Birth: Male data is updated yearly, averaging 56.615 Year from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 74.882 Year in 2016 and a record low of 45.706 Year in 1960. Iran IR: Life Expectancy at Birth: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Iran – Table IR.World Bank: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

Ecuador EC: Life Expectancy at Birth: Male data was reported at 73.636 Year in 2016. This records an increase from the previous number of 73.402 Year for 2015. Ecuador EC: Life Expectancy at Birth: Male data is updated yearly, averaging 65.622 Year from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 73.636 Year in 2016 and a record low of 51.955 Year in 1960. Ecuador EC: Life Expectancy at Birth: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Ecuador – Table EC.World Bank: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

Denmark DK: Life Expectancy at Birth: Male data was reported at 78.900 Year in 2016. This records an increase from the previous number of 78.800 Year for 2015. Denmark DK: Life Expectancy at Birth: Male data is updated yearly, averaging 71.990 Year from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 78.900 Year in 2016 and a record low of 70.200 Year in 1965. Denmark DK: Life Expectancy at Birth: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Denmark – Table DK.World Bank: Health Statistics. Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.; ; (1) United Nations Population Division. World Population Prospects: 2017 Revision. (2) Census reports and other statistical publications from national statistical offices, (3) Eurostat: Demographic Statistics, (4) United Nations Statistical Division. Population and Vital Statistics Reprot (various years), (5) U.S. Census Bureau: International Database, and (6) Secretariat of the Pacific Community: Statistics and Demography Programme.; Weighted average;

Life expectancy is the number of years a person would be expected to live, starting from birth (for life expectancy at birth) or at age 65 (for life expectancy at age 65), on the basis of the mortality statistics for a given observation period. Life expectancy is a widely used indicator of the health of a population. Life expectancy measures quantity rather than quality of life.

Namur - Population - Life expectancy - Difference between women and men Difference from the average of the municipality (4.13 years) Considering that the difference in life expectancy between the two sexes should be as small as possible, Neighborhoods with a smaller difference are in a more favourable situation (in red) than those with a larger difference (in blue)

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138

Dataset replaced by: http://data.europa.eu/euodp/data/dataset/CqVGoZOuX5iYMx8mHY0yw The indicator Healthy Life Years (HLY) at birth measures the number of years that a person at birth is still expected to live in a healthy condition. HLY is a health expectancy indicator which combines information on mortality and morbidity. The data required are the age-specific prevalence (proportions) of the population in healthy and unhealthy conditions and age-specific mortality information. A healthy condition is defined by the absence of limitations in functioning/disability. The indicator is calculated separately for males and females. The indicator is also called disability-free life expectancy (DFLE). Life expectancy at birth is defined as the mean number of years still to be lived by a person at birth -, if subjected throughout the rest of his or her life to the current mortality conditions.